SEC Form 4 · accession 0001179110-16-020746
SUNESIS PHARMACEUTICALS INC · SNSS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Bjerkholt
Officer — EVP, CFO & Corp. Secretary
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 7:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061027
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 29, 2016 | A | 80,000 | $0.00 | A | 135,913 | D | |
| Common StockF3 | Feb 29, 2016 | F | 34,991 | $0.75 | D | 100,922 | D | |
| Commmon StockF4 | holding | — | — | — | 83,827 | I | See footnote. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents an incentive bonus paid to the reporting person pursuant to the Issuer's 2015 Bonus Plan. In accordance with the terms of the 2015 Bonus Plan, the reporting person received 50% of his bonus payment in a number of shares of the Issuer's common stock calculated as set forth in the 2015 Bonus Plan.
- F2Includes 6,000 ESPP shares acquired on 11/30/15.
- F3Represents shares held by the Issuer in accordance with Rule 16b-3 to satisfy tax withholding obligations in connection with the incentive bonus paid to the reporting person pursuant to the Issuer's 2015 Bonus Plan, as reported herein.
- F4The shares are held by the Bjerkholt/Hahn Family Trust for which reporting person is Trustee.